Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Korro Bio, Inc. issued 4,501,928 shares of common stock to institutional accredited investors for $11.11 per share.
- Security
- common stock
- Shares
- 4,501,928 shares
- Purchaser
- institutional accredited investors
- Consideration
- $11.11 per share
Exact text from the filing
4(a)(2) of the Securities Act of 1933, as amended, or the 1933 Act: (i) an aggregate of 4,501,928 shares of its common stock, par value $0.001 per share at a purchase price of $11.11 per share and (ii) pre-funded warrants to acquire an aggregate of 3,148,836 shares of its common stock at a purchase price of $11.109 per pre-funded warrant. The private placement
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Korro Bio, Inc. issued 3,148,836 shares of warrant to institutional accredited investors for $11.109 per pre-funded warrant.
- Security
- warrant
- Shares
- 3,148,836 shares
- Purchaser
- institutional accredited investors
- Consideration
- $11.109 per pre-funded warrant
Exact text from the filing
pre-funded warrants to acquire an aggregate of 3,148,836 shares of its common stock at a purchase price of $11.109 per pre-funded warrant
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Korro Bio, Inc. entered into subscription agreement with a number of institutional accredited investors valued at approximately $85.0 million (effective 2026-03-09).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- a number of institutional accredited investors
- Value
- approximately $85.0 million
- Effective
- 2026-03-09
Exact text from the filing
Korro Bio, Inc., or Korro, entered into a subscription agreement with a number of institutional accredited investors pursuant to which it agreed to sell and issue in a private placement
View on SEC.gov